Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina.
Saved in:
| Title: | Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. |
|---|---|
| Authors: | Salkić N; Department of Internal Medicine, School of Medicine Tuzla, University of Tuzla, Tuzla, Bosnia and Herzegovina., Bašić Denjagić M; Department of Gastroenterology and Hepatology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina., Zubčević N; Clinic of Gastroenterohepatology, University Clinical Center of Sarajevo, Sarajevo, Bosnia and Herzegovina., Tamburić R; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina., Husić Selimović A; Department of Internal Medicine, General Hospital 'Abdulah Nakaš' Sarajevo, Sarajevo, Bosnia and Herzegovina., Babić E; Department of Gastroenterology and Hepatology, University Clinical Hospital of Mostar, Mostar, Bosnia and Herzegovina., Bevanda M; Department of Gastroenterology and Hepatology, University Clinical Hospital of Mostar, Mostar, Bosnia and Herzegovina., Saray A; Clinic of Gastroenterohepatology, University Clinical Center of Sarajevo, Sarajevo, Bosnia and Herzegovina., Jovanović P; Department of Internal Medicine, School of Medicine Tuzla, University of Tuzla, Tuzla, Bosnia and Herzegovina; Department of Gastroenterology and Hepatology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina., Tošić Z; Department of Gastroenterology, Health Center Brčko, Brčko, Bosnia and Herzegovina., Dobrovoljski A; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina., Barać T; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina. |
| Source: | Biomolecules & biomedicine [Biomol Biomed] 2024 Sep 06; Vol. 24 (5), pp. 1400-1406. Date of Electronic Publication: 2024 Sep 06. |
| Publication Type: | Journal Article; Observational Study; Multicenter Study |
| Journal Info: | Publisher: Association of Basic Medical Sciences of FBIH Country of Publication: Bosnia and Herzegovina NLM ID: 9918522188506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2831-090X (Electronic) Linking ISSN: 28310896 NLM ISO Abbreviation: Biomol Biomed Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38683174 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Salkić+N%22">Salkić N</searchLink>; Department of Internal Medicine, School of Medicine Tuzla, University of Tuzla, Tuzla, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Bašić+Denjagić+M%22">Bašić Denjagić M</searchLink>; Department of Gastroenterology and Hepatology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Zubčević+N%22">Zubčević N</searchLink>; Clinic of Gastroenterohepatology, University Clinical Center of Sarajevo, Sarajevo, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Tamburić+R%22">Tamburić R</searchLink>; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Husić+Selimović+A%22">Husić Selimović A</searchLink>; Department of Internal Medicine, General Hospital 'Abdulah Nakaš' Sarajevo, Sarajevo, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Babić+E%22">Babić E</searchLink>; Department of Gastroenterology and Hepatology, University Clinical Hospital of Mostar, Mostar, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Bevanda+M%22">Bevanda M</searchLink>; Department of Gastroenterology and Hepatology, University Clinical Hospital of Mostar, Mostar, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Saray+A%22">Saray A</searchLink>; Clinic of Gastroenterohepatology, University Clinical Center of Sarajevo, Sarajevo, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Jovanović+P%22">Jovanović P</searchLink>; Department of Internal Medicine, School of Medicine Tuzla, University of Tuzla, Tuzla, Bosnia and Herzegovina; Department of Gastroenterology and Hepatology, University Clinical Center of Tuzla, Tuzla, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Tošić+Z%22">Tošić Z</searchLink>; Department of Gastroenterology, Health Center Brčko, Brčko, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Dobrovoljski+A%22">Dobrovoljski A</searchLink>; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina.<br /><searchLink fieldCode="AU" term="%22Barać+T%22">Barać T</searchLink>; Clinic of Gastroenterology and Hepatology, University Clinical Center of Republic of Srpska, Banja Luka, Bosnia and Herzegovina. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918522188506676%22">Biomolecules & biomedicine</searchLink> [Biomol Biomed] 2024 Sep 06; Vol. 24 (5), pp. 1400-1406. <i>Date of Electronic Publication: </i>2024 Sep 06. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Observational Study; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Association+of+Basic+Medical+Sciences+of+FBIH%22">Association of Basic Medical Sciences of FBIH </searchLink><i>Country of Publication: </i>Bosnia and Herzegovina <i>NLM ID: </i>9918522188506676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2831-090X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2228310896%22">28310896 </searchLink><i>NLM ISO Abbreviation: </i>Biomol Biomed <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38683174 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.17305/bb.2024.10433 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1400 Titles: – TitleFull: Short-term efficacy of vedolizumab in patients with inflammatory bowel disease in real-life settings in Bosnia and Herzegovina. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Salkić N – PersonEntity: Name: NameFull: Bašić Denjagić M – PersonEntity: Name: NameFull: Zubčević N – PersonEntity: Name: NameFull: Tamburić R – PersonEntity: Name: NameFull: Husić Selimović A – PersonEntity: Name: NameFull: Babić E – PersonEntity: Name: NameFull: Bevanda M – PersonEntity: Name: NameFull: Saray A – PersonEntity: Name: NameFull: Jovanović P – PersonEntity: Name: NameFull: Tošić Z – PersonEntity: Name: NameFull: Dobrovoljski A – PersonEntity: Name: NameFull: Barać T IsPartOfRelationships: – BibEntity: Dates: – D: 06 M: 09 Text: 2024 Sep 06 Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 2831-090X Numbering: – Type: volume Value: 24 – Type: issue Value: 5 Titles: – TitleFull: Biomolecules & biomedicine Type: main |
| ResultId | 1 |